Company: BDRX
Filing Date: 2025-01-28
Form Type: 424B3
Source: 0001214659-25-001409
Chunk: 120

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-28
Form: 424B3
Chunk 120
---
 sale by the Selling Shareholder for resale under this prospectus is dependent upon the number of Depositary Shares,
if any, we ultimately sell to the Selling Shareholder under the Purchase Agreement. Further, if and when we elect to sell Depositary Shares
to the Selling Shareholder pursuant to the Purchase Agreement, after the Selling Shareholder has acquired such shares, the Selling Shareholder
may resell all, some or none of such Depositary Shares at any time or from time to time in its discretion and at different prices.

The issuance of our Depositary
Shares to the Selling Shareholder pursuant to the Purchase Agreement will not affect the rights or privileges of our existing shareholders,
except that the economic and voting interests of each of our existing shareholders will be diluted. Although the number of Depositary
Shares that our existing shareholders own will not decrease, the Depositary Shares (and the underlying Ordinary Shares) owned by our existing
shareholders will represent a smaller percentage of our total outstanding Ordinary Shares after any such issuance.

The following table sets forth
the amount of gross proceeds we may receive from the Selling Shareholder from our sale of Purchase Shares that we may issue and sell to
the Selling Shareholder from time to time under the Purchase Agreement assuming that all such Purchase Shares are sold at varying purchase
prices designated below:

| Assumed Purchase Price 
 Per Share (1)          |         |     | Total Number of Purchase Shares to be Issued if 
 Full Purchase                                   |            |     | Percentage of Outstanding                  
 Ordinary Shares After Giving Effect to the 
 Issuance of Purchase Shares to Selling     
 Shareholder (2)                            |       |     | Proceeds from the Sale of the Purchase Shares to the Selling 
 Shareholder (3)                                              |            |
|:-----------------------|--------:|:----|:------------------------------------------------|-----------:|:----|:-------------------------------------------|:------|:----|:-------------------------------------------------------------|-----------:|
| $                      |    1.00 |     |                                                 | 35,000,000 |     |                                            | 98.1% |     | $                                                            | 35,000,000 |
| $                      | 4.13(4) |     |                                                 |  8,474,576 |     |                                            | 92.7% |     | $                                                            | 35,000,000 |
| $                      |    5.00 |     |                                                 |  7,000,000 |     |                                            | 91.3%